It is sparingly soluble in water
[16] [18] There is insufficient evidence to determine the risk of adverse outcomes in human pregnancies, and thus, use during pregnancy should be guided by clinical judgment and individual risk assessment
Simply input your concerns and well provide custom treatment recommendations for your unique needs.
In diet-induced obese mice (16 weeks HFD), subcutaneous 5-Amino-1MQ treatment for 11 days (20 mg/kg/injection, three injections daily) produced significantly reduced body weights, white adipose tissue masses, and adipocyte cell sizes compared to vehicle controls
Your AlluraMD provider will consult with you to ensure that AOD 9604 is appropriate for your specific health needs and goals
5-Amino-1MQ Side Effects and Safety Questions Because human safety data is limited, the side effect profile of 5-Amino-1MQ is not fully established